Table 1 Demographics and Baseline Characteristics
Characteristic | Result |
|---|---|
Demographics | |
Values stated in median and (range) | |
Gender | |
Male | 5/17 (29.4%) |
Female | 12/17 (70.6%) |
Age at death (years) (N = 15); | 63 (18–81) |
Age at implant (years) (N = 17) | 63 (18–81) |
Height (cm) (N = 15) | 164 (152–177) |
Weight (kg) (N = 16) | 69 (52–128) |
BMI (kg/m2) (N = 14) | 25.5 (18.2–41.3) |
Aetiology of ascites: Primary Cancer Type | |
Ovarian | 5/17 (29.4%) |
Breast | 1/17 (5.9%) |
Uterine | 1/17 (5.9%) |
Pancreatic | 1/17 (5.9%) |
Hepatic | 6/17 (35.3%) |
Cholangiocarcinoma | 2/17 (11.8%) |
Renal | 1/17 (5.9%) |
Comorbidities of interest (predefined) | |
Cardiovascular disordersa | 11/17 (64.7%) |
Hepatobiliary disordersb | 5/17 (29.4%) |
Haematologic and lymphatic disordersc | 3/17 (17.6%) |
Endocrine disordersd | 2/17 (11.8%) |
Gastrointestinal disorderse | 3/17 (17.6%) |
Metabolic and nutritional disordersf | 7/17 (41.2%) |
Musculoskeletal and connective tissue disordersg | 2/17 (11.8%) |
Nervous system disordersh | 1/17 (5.9%) |
Respiratory, thoracic and mediastinal disordersi | 1/17 (5.9%) |
Skin and subcutaneous tissue disordersj | 2/17 (11.8%) |